The Development Prospect Of APIs in China

First of all, the global pharmaceutical market is expected to maintain a growth rate of more than 8% in 2014, the emerging pharmaceutical market is likely to maintain a greater growth rate, and the international and domestic market demand for APIs will continue to grow.
Secondly, many of China's APIs occupy a high market share in the international market, with obvious scale advantages, which cannot be replaced by other countries in the short term.
Third, although the price of Chinese APIs has risen significantly due to multiple factors, these rising factors are rigid, and it is unlikely that it will decline significantly in 2013 and affect the total export of Chinese APIs. From the perspective of API imports in 2012, the average price increased by 28.21%, and the comparative advantage of China's API price still exists under the general rise in global API prices.
Fourth, the efforts of Chinese enterprises to avoid homogeneous competition, develop characteristic APIs, and many enterprises target the developed country market, actively pass high-end market certification, and continuously improve the quality of export products, which will expand the export space of Chinese APIs.
Fifth, the continuous introduction and implementation of the state's export policy will also play an important role in promoting the export growth of APIs.